2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
29
Breast Neoplasms
28
Brain Neoplasms
21
Neoplasms
16
Glioma
10
Pancreatic Neoplasms
9
Head and Neck Neoplasms
8
Lymphoma
7
Uterine Cervical Neoplasms
6
Urinary Bladder Neoplasms
6
Rectal Neoplasms
6
Glioblastoma
6
Colonic Neoplasms
6
Carcinoma, Hepatocellular
6
Lymphoma, Non-Hodgkin
5
Lung Neoplasms
5
Astrocytoma
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Liver Neoplasms
4
Disease
4
Central Nervous System Neoplasms
4
Stomach Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Esophageal Neoplasms
3
Carcinoma in Situ
3
Retinoblastoma
2
Pathologic Complete Response
2
Interventions
Carboplatin
7
Trastuzumab
6
Docetaxel
5
pembrolizumab
4
Paclitaxel
4
Oxaliplatin
4
Fluorouracil
4
Cytarabine
4
Cyclophosphamide
4
Azacitidine
4
pertuzumab
3
Radiotherapy
3
Observation
3
Neoadjuvant Therapy
3
Epirubicin
3
Endoscopy
3
Cisplatin
3
Chemoradiotherapy
3
Capecitabine
3
venetoclax
2
toripalimab
2
sargramostim
2
olaparib
2
durvalumab
2
cc-486
2
Tretinoin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Monatide (IMS 3015)
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Magnetic Resonance Imaging
×
Clear all
NCT07472868
2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3
Not yet recruiting
394 enrolled
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled